StockData
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc. (CURLF) stock

CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026Market cap $2.07BP/E –Yield –

Curaleaf r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was $805.00K, down 43.3% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$805.00K-43.3%
FY2024Dec 31, 2024$1.42M–

More Curaleaf figures

See a number that looks wrong?